Drug Trial Radar · NCT02528188
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Last checked: Nov 19, 2026Latest source record: Jan 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,021
Actual
Start
Jul 21, 2015
Primary completion
Oct 5, 2018
Study completion Feb 27, 2019
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 19, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees.
Conditions
- Chronic Pain
- Osteoarthritis, Hip
- Osteoarthritis, Knee
Interventions
NSAIDDrug
Orally administered NSAID (naproxen 500 mg, celecoxib 100 mg or diclofenac 75 mg) twice daily for 56 weeks
Tanezumab 2.5 mgBiological
Subcutaneous injection of tanezumab 2.5 mg every 8 weeks for 56 weeks
Tanezumab 5 mgBiological
Subcutaneous injection of tanezumab 5 mg every 8 weeks for 56 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Adjudicated Primary Composite Joint Safety OutcomeTime frame: Baseline up to Week 80
- Observation Time-Adjusted Event Rate of Participants With Adjudicated Primary Composite Joint Safety OutcomeTime frame: Baseline up to Week 80
- Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale at Week 16Time frame: Baseline, Week 16
- Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Physical Function Subscale at Week 16Time frame: Baseline, Week 16
- Change From Baseline in Patient's Global Assessment (PGA) of Osteoarthritis at Week 16Time frame: Baseline, Week 16
Locations
507 sites in 18 countries. Site status is shown where the registry gives one.
Central Alabama Research
Birmingham, Alabama
Achieve Clinical Research, LLC
Birmingham, Alabama
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama
Alabama Orthopaedic Surgeons
Birmingham, Alabama
Rheumatology Associates of North Alabama, PC
Huntsville, Alabama
Coastal Clinical Research, Inc.
Mobile, Alabama
Ferguson Family Medicine
Mesa, Arizona
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, Arizona
Arizona Research Center
Phoenix, Arizona
Valley Pain Consultants
Scottsdale, Arizona
Clinical Research Consortium
Tempe, Arizona
Noble Clinical Research, LLC
Tucson, Arizona
Quality of Life Medical & Research Centers, LLC
Tucson, Arizona
Tucson Orthopaedic Institute - Research Center
Tucson, Arizona
CHI St. Vincent Medical Group Hot Springs
Hot Springs, Arkansas
Chrystal Johnson
Little Rock, Arkansas
KLR Business Group, Inc., dba Arkansas Clinical Research
Little Rock, Arkansas
Larry Watkins, MD
Little Rock, Arkansas
Lynn Institute of the Ozarks
Little Rock, Arkansas
Orange County Research Institute
Anaheim, California
Advanced Research Center
Anaheim, California
CITrials
Bellflower, California
Osteoporosis Medical Center
Beverly Hills, California
Hope Clinical Research
Canoga Park, California
Med Center
Carmichael, California
Core Healthcare Group
Cerritos, California
Pleitez Medical Clinic
Covina, California
Triwest Research Associates, LLC
El Cajon, California
T. Joseph Raoof MD, INC/Encino Research Center
Encino, California
San Diego Imaging Escondido
Escondido, California
Med Investigations, Inc.
Fair Oaks, California
Research Center of Fresno, Inc.
Fresno, California
Neuro-Pain Medical Center
Fresno, California
Collaborative Neuroscience Network, LLC.
Garden Grove, California
Allied Clinical Research
Gold River, California
HealthCare Partners Clinical Research, LLC.
Huntington Beach, California
Marvel Clinical Research LLC
Huntington Beach, California
BioSolutions Clinical Research Center
La Mesa, California
eStudySite
La Mesa, California
Arthritis & Osteoporosis Medical Center
La Palma, California
Showing 40 of 507 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.